Novel Gene Abnormality in Epilepsy with Myoclonic-Atonic Seizures (Doose Syndrome)
DOI:
https://doi.org/10.46570/utjms.vol11-2023-551Keywords:
Epilepsy, Genetics, Doose Syndrome, Myoclonic-Atonic SeizuresAbstract
Introduction:
Doose Syndrome is a myoclonic-atonic seizure disorder most prominent in the pediatric population. Several common genetic mutations have been identified. However, SUOX gene mutations have not yet been correlated with Doose Syndrome.
Case Report:
At the age of 5, the patient presented with absence seizures followed by the development of generalized tonic-clonic and myoclonic-atonic seizures. She was diagnosed with Doose Syndrome based on her clinical presentation and EEG findings. An MRI found an incidental left choroidal fissure cyst. Multiple medical interventions failed to control seizures. To date, the patient has shown partial response to clobazam (40 mg/day), phenobarbital (97.5 mg/day), and a ketogenic diet.
Conclusion:
SUOX gene defects have been associated with isolated sulfite oxidase deficiency. However, our patient did not have the typical presentation, progression, and symptomology of this disorder. Instead, several possible sources for the seizures were identified; the mutation itself, focal seizures originating from the brain lesion which then generalizes mimicking Doose Syndrome, or a synergistic role between the cyst and genetic mutation.
References
Zhou, P, He, N, Zhang, J?W, et al. Novel mutations and phenotypes of epilepsy?associated genes in epileptic encephalopathies. Genes, Brain and Behavior. 2018; 17:e12456. https://doi.org/10.1111/gbb.12456 DOI: https://doi.org/10.1111/gbb.12456
Doose H, Gerken H, Leonhardt R, Volzke E, Volz C. Centrencephalic myoclonic–astatic petit mal. Clinical and genetic investigations. Neuropediatrie 1970; 2: 59–78. (In German) DOI: https://doi.org/10.1055/s-0028-1091841
Oguni H, Tanaka T, Hayashi K, et al. Treatment and long?term prognosis of myoclonic–astatic epilepsy of early childhood. Neuropediatrics 2002; 33: 122–32. DOI: https://doi.org/10.1055/s-2002-33675
Neubauer BA, Hahn A, Doose H, Tuxhorn I. Myoclonic–astatic epilepsy of early childhood – definition, course, nosography and genetics. Adv Neurol 2005; 95: 147–55.
Scheffer I. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479–90. DOI: https://doi.org/10.1093/brain/120.3.479
Dimova P, Yordanova I, Bojinova V, Jordanova A, Kremenski I. Generalized epilepsy with febrile seizures plus: Novel SCN1A mutation. Pediatr Neurol 2010; 42: 137–40. DOI: https://doi.org/10.1016/j.pediatrneurol.2009.09.007
Carvill GL, Mcmahon JM, Schneider A, et al. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic?atonic seizures. Am J Hum Genet. 2015;96:808?815. DOI: https://doi.org/10.1016/j.ajhg.2015.02.016
Mullen SA, Marini C, Suls A, et al. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol. 2011;68:1152?1155. DOI: https://doi.org/10.1001/archneurol.2011.102
Bindu PS, Nagappa M, Bharath RD, et al. Isolated Sulfite Oxidase Deficiency. 2017 Sep 21. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK453433/
Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010 Nov;52(11):988-93. doi: 10.1111/j.1469-8749.2010.03744.x. Epub 2010 Aug 16. PMID: 20722665. DOI: https://doi.org/10.1111/j.1469-8749.2010.03744.x
Achour, A., Mnari, W., Miladi, A., Hmida, B., Maatouk, M., Golli, M., & Zrig, A. (2020). Temporal choroidal fissure cyst: a rare cause of temporal lobe epilepsy. The Pan African medical journal, 36, 120. https://doi.org/10.11604/pamj.2020.36.120.21327 DOI: https://doi.org/10.11604/pamj.2020.36.120.21327
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rayan Magsi, Casey Ryan, Ajaz Sheikh, Mariam Noor, Naeem Mahfooz
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
